3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
42
Thoracic
2
Gastrointestinal
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
76
Anemia, Refractory, with Excess of Blasts
72
Myelodysplastic Syndromes
69
Leukemia
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Anemia
50
Leukemia, Lymphocytic, Chronic, B-Cell
44
Leukemia, Myelomonocytic, Chronic
42
Lymphoma, Non-Hodgkin
41
Multiple Myeloma
38
Hodgkin Disease
36
Myeloproliferative Disorders
34
Primary Myelofibrosis
33
Thrombocytopenia
32
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
32
Lymphoma
31
Neoplasms
29
Anemia, Aplastic
29
Congenital Abnormalities
27
Anemia, Refractory
25
Lymphoma, Follicular
23
Lymphoma, Mantle-Cell
21
Lymphoma, B-Cell, Marginal Zone
18
Burkitt Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
17
Leukemia, Myeloid, Chronic-Phase
17
Venous Thromboembolism
16
Lymphoma, Large-Cell, Immunoblastic
16
Leukemia, Myeloid, Accelerated Phase
16
Waldenstrom Macroglobulinemia
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Breast Carcinoma In Situ
×
Classical hematology
×
Clear all
NCT02728596
2022-10-20
TrACER
SWOG Cancer Research Network
Phase NA
Completed
3,665 enrolled
17 charts